Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20937)

• Formulation Name: Terazosin 2 mg capsule
• Company: RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terazosin	(DM3JCVS)	Benign prostatic hyperplasia	GA90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Aluminum chlorohydrex propylene glycol	(E00594)	71587575	Other agent
Crospovidone	(E00626)	Not Available	Disintegrant
FD&C blue no. 1	(E00263)	19700	Colorant
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Quinoline yellow WS	(E00309)	24671	Colorant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent